TNF-alpha-inhibiting thiothalidomides(Phase 2 Discovery)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTNF-alpha-inhibiting thiothalidomides(Phase 2 Discovery)
Drug Alias NameTNF-alpha-inhibiting hydroxythalidomides(P2D)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhase 2 Discovery
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A